- Home
- BBD vs WST Comparison
BBD vs WST Comparison
Compare BBD & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBD | WST |
|---|---|---|
| Founded | 1943 | 1923 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.6B | 20.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BBD | WST |
|---|---|---|
| Price | $3.49 | $271.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $2.55 | ★ $346.78 |
| AVG Volume (30 Days) | ★ 37.3M | 661.3K |
| Earning Date | 10-29-2025 | 10-23-2025 |
| Dividend Yield | ★ 4.81% | 0.33% |
| EPS Growth | ★ 47.11 | 0.17 |
| EPS | 0.38 | ★ 6.75 |
| Revenue | ★ $16,507,289,161.00 | $3,017,900,000.00 |
| Revenue This Year | $78.26 | $7.01 |
| Revenue Next Year | $7.53 | $6.20 |
| P/E Ratio | ★ $8.46 | $39.63 |
| Revenue Growth | ★ 16.68 | 4.92 |
| 52 Week Low | $1.84 | $187.43 |
| 52 Week High | $3.77 | $348.90 |
Technical Indicators
Market Signals| Indicator | BBD | WST |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 49.70 |
| Support Level | $3.22 | $265.39 |
| Resistance Level | $3.73 | $274.56 |
| Average True Range (ATR) | 0.10 | 7.11 |
| MACD | -0.02 | -0.59 |
| Stochastic Oscillator | 51.96 | 38.85 |
Price Performance
Historical ComparisonAbout BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.